AIM: £4.32 (+0) | Nasdaq: $29.21 (-0.55)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
商业平台, 监管信息公告 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture